Elucidating the dynamics of the neutralizing antibody (nAb) response in coronavirus disease
2019 (COVID-19) convalescents is crucial in controlling the pandemic and informing …

B cells are important in immunity to both severe acute respiratory syndrome coronavirus-2
(SARS-CoV-2) infection and vaccination, but B cell receptor (BCR) repertoire development …

SARS‐CoV‐2 vaccines are highly efficient against severe forms of the disease,
hospitalization and death. Nevertheless, insufficient protection against several circulating …

Background We aimed to estimate the seroprevalence of SARS-CoV-2 infection in France
and to identify the populations most exposed during the first epidemic wave. Methods …

Background COVID-19 has caused more than 2.6 billion infections and several million
deaths since its outbreak 2 years ago. We know very little about the long-term cellular …

Background As of 2022, inactivated SARS-CoV-2 vaccines had been used in more than 91
countries. However, limited real world information was available on the immune responses …

To understand the determinants of long-term immune responses to severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) and the concurrent impact of vaccination and …

Background Antibody response to SARS-CoV-2 is a valuable biomarker for the assessment
of the spread of the virus in a population and evaluation of the vaccine candidates. Recent …

Background: Mycobacterium bovis Bacillus Calmette-Guérin (BCG) is a live attenuated
vaccine mainly administered to newborns and used for over 100 years to prevent the …

As global vaccination campaigns against SARS-CoV-2 proceed, there is particular interest
in the longevity of immune protection, especially with regard to increasingly infectious virus …